These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 39293087)

  • 1. Handling delayed or missed direct oral anticoagulant doses: model-informed individual remedial dosing.
    Liu XQ; Li ZR; Wang CY; Jiao Z
    Blood Adv; 2024 Sep; ():. PubMed ID: 39293087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Handling Delayed or Missed Dose of Antiseizure Medications: A Model-Informed Individual Remedial Dosing.
    Li ZR; Wang CY; Lin WW; Chen YT; Liu XQ; Jiao Z
    Neurology; 2023 Feb; 100(9):e921-e931. PubMed ID: 36450606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to handle the delayed or missed dose of rivaroxaban in patients with non-valvular atrial fibrillation: model-informed remedial dosing.
    Liu XQ; Yin YW; Wang CY; Li ZR; Zhu X; Jiao Z
    Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1153-1163. PubMed ID: 34058934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to handle a delayed or missed dose of edoxaban in patients with non-valvular atrial fibrillation? A model-informed remedial strategy.
    Yin YW; Liu XQ; Gu JQ; Li ZR; Jiao Z
    Br J Clin Pharmacol; 2023 Jul; 89(7):2066-2075. PubMed ID: 35332559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and Dosing Regimens of Direct Oral Anticoagulants in Morbidly Obese Patients: An Updated Literature Review.
    Zhao Y; Guo M; Li D; Xu W; Pan C; He C; Cui X
    Clin Appl Thromb Hemost; 2023; 29():10760296231153638. PubMed ID: 36760080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remedial dosing recommendations for delayed or missed doses of lamotrigine in pediatric patients with epilepsy using Monte Carlo simulations.
    Yu EQ; Jiao Z; Wang CY; Ding JJ; Zhang XH
    Epilepsy Behav; 2019 Jul; 96():132-140. PubMed ID: 31132614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remedial dosing recommendations for delayed or missed doses of valproic acid in patients with epilepsy based on Monte Carlo simulations.
    Wang CY; Jiao Z; Ding JJ; Yu EQ; Zhu GX
    Epilepsy Behav; 2020 Oct; 111():107265. PubMed ID: 32640410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing delayed or missed pregabalin doses in patients with focal epilepsy: a Monte Carlo simulation study.
    Xie H; Zheng Y; Wang C; Song S; Dai Y; Huang X; Liu M; Wu X
    Int J Clin Pharm; 2024 Feb; 46(1):150-157. PubMed ID: 37991662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remedial Dosing Recommendations for Sirolimus Delayed or Missed Dosages Caused by Poor Medication Compliance in Pediatric Tuberous Sclerosis Complex Patients.
    Yang Y; Jiang L; Zhu HR; Sun WX; Mao JY; Miao JW; Wang YC; He SM; Wang DD; Chen X
    Curr Pharm Des; 2024; 30(11):877-886. PubMed ID: 38454763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-based precision dosing and remedial dosing recommendations for delayed or missed doses of isoniazid in Chinese patients with tuberculosis.
    Li JM; Zhang RY; Yang GY; Cai QS; Lang YZ; Zhong FM; Huang JP; Chen YY; Qin Y; Fang LK; Ye B; Lin LH; Lin HH; Cai XJ; Xu K
    Br J Clin Pharmacol; 2024 Apr; ():. PubMed ID: 38570184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilemmas Related to Direct-Acting Oral Anticoagulant Administration in Patients With Extreme Obesity.
    Erstad BL; Barletta JF
    Ann Pharmacother; 2023 Jun; 57(6):727-737. PubMed ID: 36258660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to Handle Delayed or Missed Doses: A Population Pharmacokinetic Perspective.
    Gu JQ; Guo YP; Jiao Z; Ding JJ; Li GF
    Eur J Drug Metab Pharmacokinet; 2020 Apr; 45(2):163-172. PubMed ID: 31792726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study.
    Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V
    Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens.
    Trujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M;
    Thromb Haemost; 2017 Jan; 117(2):382-389. PubMed ID: 27786333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Older Adults with Atrial Fibrillation: A Structured Narrative Review.
    Edwina AE; Dia N; Dreesen E; Vanassche T; Verhamme P; Spriet I; Van der Linden L; Tournoy J
    Clin Pharmacokinet; 2023 Mar; 62(3):351-373. PubMed ID: 36862336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct Oral Anticoagulant (DOAC) Dosing in Patients with Non-valvular Atrial Fibrillation (NVAF) in the United Kingdom: A Retrospective Cohort Study Using CPRD Gold Database.
    Khachatryan A; Doobaree IU; Spentzouris G; Gusto G; Zawaneh Y; Mughal F; Anastassopoulou A; Manu M; Fay M
    Adv Ther; 2023 Feb; 40(2):504-520. PubMed ID: 36399317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Patients with Renal Failure.
    Padrini R
    Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):1-12. PubMed ID: 30167998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to handle a missed or delayed dose of lacosamide in pediatric patients with epilepsy? a mode-informed individual dosing.
    Wang J; Mei Y; Liang S; Li SC; Chen C; Nie G; Tuo YL; Sun D; Wang Y
    Epilepsy Behav; 2024 Feb; 151():109601. PubMed ID: 38194771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative differences in the risk of major gastrointestinal bleeding among different direct oral anticoagulants: An updated traditional and Bayesian network meta-analysis.
    Chen X; Wang L; Li H; Huang W; Zhao L; Guo W
    Front Pharmacol; 2022; 13():1049283. PubMed ID: 36686666
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review.
    Bikdeli B; Zahedi Tajrishi F; Sadeghipour P; Talasaz AH; Fanikos J; Lippi G; Siegal DM; Eikelboom JW; Monreal M; Jimenez D; Connors JM; Ageno W; Barnes GD; Piazza G; Angiolillo DJ; Parikh SA; Kirtane AJ; Lopes RD; Bhatt DL; Weitz JI; Mehran R; Krumholz HM; Goldhaber SZ; Lip GYH
    JAMA Cardiol; 2022 Jul; 7(7):747-759. PubMed ID: 35648414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.